Abstract

The use of antiretroviral therapy has reduced mortality and increased the quality of life of HIV-1-infected people, particularly in more developed countries where access to treatment is more widespread. However, morbidities continue, which include HIV-1-associated neurocognitive disorders (HAND). Subtle cognitive abnormalities and low-level viral replication underlie disease. The balance between robust antiviral adaptive immunity, neuronal homeostatic mechanisms, and neuroprotective factors on one hand and toxicities afforded by dysregulated immune activities on the other govern disease. New insights into the pathobiological processes for neuroimmune-linked disease and ways to modulate such activities for therapeutic gain are discussed. Better understanding of the complexities of immune regulation during HAND can improve diagnosis and disease outcomes but is also relevant for the pathogenesis of a broad range of neurodegenerative disorders.

Original languageEnglish (US)
Pages (from-to)133-145
Number of pages13
JournalNeuron
Volume64
Issue number1
DOIs
StatePublished - Oct 15 2009

Fingerprint

Virus Diseases
Color
HIV
HIV-1
Neuroimmunomodulation
Adaptive Immunity
Developed Countries
Neurodegenerative Diseases
Antiviral Agents
Therapeutics
Quality of Life
Morbidity
Mortality
Neurocognitive Disorders

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

A Coat of Many Colors : Neuroimmune Crosstalk in Human Immunodeficiency Virus Infection. / Kraft-Terry, Stephanie D.; Buch, Shilpa J; Fox, Howard S; Gendelman, Howard Eliot.

In: Neuron, Vol. 64, No. 1, 15.10.2009, p. 133-145.

Research output: Contribution to journalReview article

@article{2d226856dc854aed8f60c9dc184a76ff,
title = "A Coat of Many Colors: Neuroimmune Crosstalk in Human Immunodeficiency Virus Infection",
abstract = "The use of antiretroviral therapy has reduced mortality and increased the quality of life of HIV-1-infected people, particularly in more developed countries where access to treatment is more widespread. However, morbidities continue, which include HIV-1-associated neurocognitive disorders (HAND). Subtle cognitive abnormalities and low-level viral replication underlie disease. The balance between robust antiviral adaptive immunity, neuronal homeostatic mechanisms, and neuroprotective factors on one hand and toxicities afforded by dysregulated immune activities on the other govern disease. New insights into the pathobiological processes for neuroimmune-linked disease and ways to modulate such activities for therapeutic gain are discussed. Better understanding of the complexities of immune regulation during HAND can improve diagnosis and disease outcomes but is also relevant for the pathogenesis of a broad range of neurodegenerative disorders.",
author = "Kraft-Terry, {Stephanie D.} and Buch, {Shilpa J} and Fox, {Howard S} and Gendelman, {Howard Eliot}",
year = "2009",
month = "10",
day = "15",
doi = "10.1016/j.neuron.2009.09.042",
language = "English (US)",
volume = "64",
pages = "133--145",
journal = "Neuron",
issn = "0896-6273",
publisher = "Cell Press",
number = "1",

}

TY - JOUR

T1 - A Coat of Many Colors

T2 - Neuroimmune Crosstalk in Human Immunodeficiency Virus Infection

AU - Kraft-Terry, Stephanie D.

AU - Buch, Shilpa J

AU - Fox, Howard S

AU - Gendelman, Howard Eliot

PY - 2009/10/15

Y1 - 2009/10/15

N2 - The use of antiretroviral therapy has reduced mortality and increased the quality of life of HIV-1-infected people, particularly in more developed countries where access to treatment is more widespread. However, morbidities continue, which include HIV-1-associated neurocognitive disorders (HAND). Subtle cognitive abnormalities and low-level viral replication underlie disease. The balance between robust antiviral adaptive immunity, neuronal homeostatic mechanisms, and neuroprotective factors on one hand and toxicities afforded by dysregulated immune activities on the other govern disease. New insights into the pathobiological processes for neuroimmune-linked disease and ways to modulate such activities for therapeutic gain are discussed. Better understanding of the complexities of immune regulation during HAND can improve diagnosis and disease outcomes but is also relevant for the pathogenesis of a broad range of neurodegenerative disorders.

AB - The use of antiretroviral therapy has reduced mortality and increased the quality of life of HIV-1-infected people, particularly in more developed countries where access to treatment is more widespread. However, morbidities continue, which include HIV-1-associated neurocognitive disorders (HAND). Subtle cognitive abnormalities and low-level viral replication underlie disease. The balance between robust antiviral adaptive immunity, neuronal homeostatic mechanisms, and neuroprotective factors on one hand and toxicities afforded by dysregulated immune activities on the other govern disease. New insights into the pathobiological processes for neuroimmune-linked disease and ways to modulate such activities for therapeutic gain are discussed. Better understanding of the complexities of immune regulation during HAND can improve diagnosis and disease outcomes but is also relevant for the pathogenesis of a broad range of neurodegenerative disorders.

UR - http://www.scopus.com/inward/record.url?scp=70349810685&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349810685&partnerID=8YFLogxK

U2 - 10.1016/j.neuron.2009.09.042

DO - 10.1016/j.neuron.2009.09.042

M3 - Review article

C2 - 19840555

AN - SCOPUS:70349810685

VL - 64

SP - 133

EP - 145

JO - Neuron

JF - Neuron

SN - 0896-6273

IS - 1

ER -